| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0bf0928b608797b70bbc2b91c7e52e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C63-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C63-06 |
| filingDate |
2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c1f28bc33645fd30365b38c255a86b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d1471c6f9e87cdba66668be4e4b7d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2499d74d76380dcf248cde9ef9bbfc30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e3c12afb2ffa3cd23a66e97df6536a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bfcc09b56fa3e00f5fa7420c9002e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af33875619046754f3e3354028e964a |
| publicationDate |
2015-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015126520-A1 |
| titleOfInvention |
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers |
| abstract |
Novel solid forms of imatinib mesilate comprising as active ingredient 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]-benzamide methanesulfonic acid salt and as co-crystal former benzoic acid, fumaric acid or succinic acid are described. The said multi-component crystalline forms possess improved physical and biological properties with respect to the crystalline forms of the active pharmaceutical ingredient previously known. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9567317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018160178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884813-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527743-B2 |
| priorityDate |
2012-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |